Invasive lobular cancer of the breast - Is breast conservation surgery a good option? [1]

Breast Journal

Volumn 12, Issue 6, 2006, Pages 574-575

  Raje, Durgesh ^a   Bollard, Ruth ^a   Wilson, Alan ^a  

^a ROYAL LANCASTER INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANASTROZOLE; TAMOXIFEN;

ADULT; BREAST BIOPSY; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; LETTER; MASTECTOMY; MULTIMODALITY CANCER THERAPY; SURGICAL TECHNIQUE;

ADULT; BREAST NEOPLASMS; CARCINOMA, LOBULAR; FEMALE; HUMANS; MASTECTOMY; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM INVASIVENESS;

EID: 33750622588     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/j.1524-4741.2006.00351.x     Document Type: Letter

References (16)

1. Hussien M, Lioe TF, Finnegan J, Spence RA, Surgical treatment for invasive lobular carcinoma of the breast. Breast 2003;12:23-35.
2. Rosen PP. The pathology of invasive breast carcinoma. In: Harris JR, Hellman S, Henderson JC, Kinne DW, eds. Breast Diseases, 2nd edn. Philadelphia: JB Lippincott, 1991:245-96.
3. Lesser ML, Rosen PP, Kinne DW. Multicentricity and bilaterality in invasive breast carcinoma. Surgery 1982;91:234-40.
4. Holland PA, Shah A, Howell A, Baildam AD, Bundred NJ. Lobular carcinoma of the breast can be managed by breast conserving therapy. Br J Surg 1995;82:1364-66.
5. Arpino G, Bardou VJ, Clark GM, Richard M. Elledge Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome. Breast Cancer Res 2004;6:R149-56 Epub 2004 Feb 17.
6. Salvadori B, Biganzoli E, Veronesi P, Saccozzi R, Rilke F. Conservative surgery for infiltrating lobular breast carcinoma. Br J Surg 1997;84:106-9.
7. Chung MA, Cole B, Wanebo HJ, Bland KI, Chang HR. Optimal surgical treatment of invasive lobular carcinoma. Ann Surg Oncol 1997;7:545-50.
8. Cabioglu N, Hunt KK, Buchholz TA, et al. Improving local control with breast- conserving therapy: a 27-year single-institution experience. Cancer 2005;104:20-29.
9. Du Toit RS, Locker AP, Ellis IO, et al. An evaluation of differences in prognosis, recurrence patterns and receptor status between invasive lobular and other invasive carcinomas of the breast. Eur J Surg Oncol 1991;17:251-57.
10. Cellini C, Huston TL, Martins D, et al. Multiple re-excisions versus mastectomy in patients with persistent residual disease following breast conservation surgery. Am J Surg 2005;189:662-66.
11. Munot K, Dall B, Achuthan R, Parkin G, Lane S, Horgan K, Role of magnetic resonance imaging in the diagnosis and single-stage surgical resection of invasive lobular carcinoma of the breast. Br J Surg 2003;90:248.
12. Boetes C, Veltman J, van Die L, Bult P, Wobbes T, Barentsz JO. The role of MRI in invasive lobular carcinoma. Breast Cancer Res Treat 2004;86:31-37.
13. Chagpar A. Intraoperative margin assessment reduces reexcision rates in patients with ductal carcinoma in situ treated with breast-conserving surgery. Am J Surg 2003;186:371-77.
14. Balch GC, Mithani SK, Simpson JF, Kelley M. Accuracy of intraoperative gross examination of surgical margin status in women undergoing partial mastectomy for breast malignancy. Am Surg 2005;71:22-27.
15. Moore MM, Borossa G, Imbrie JZ, et al. Association of infiltrating lobular carcinoma with positive surgical margins after breast-conservation therapy. Ann Surg 2000;231:877-82.
16. Elder EE, Brandberg Y, Bjorklund T, et al. Quality of life and patient satisfaction in breast cancer patients after immediate breast reconstruction: a prospective study. Breast 2005;14:201-8.